Legislative Research: US HB9321 | 2021-2022 | 117th Congress

Other Sessions

SessionTitle/DescriptionLast Action
2023-2024
118th Congress

(Introduced)
To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
[HB9321 2023 Detail][HB9321 2023 Text][HB9321 2023 Comments]
2024-12-17
Referred to the Subcommittee on Health.
2021-2022
117th Congress

(Introduced - Dead)
To amend the Public Health Service Act to provide for the development and publication of independent value assessments for drugs, and for other purposes.
[HB9321 2021 Detail][HB9321 2021 Text][HB9321 2021 Comments]
2022-11-17
Referred to the Subcommittee on Health.

References Online

Search PhraseWebNewsFinancialFinancialEncylopediaBiographyBioGuide
[US Congress HB9321]Google WebGoogle News
[US Congress House Subcommittee on Health Committee]Google WebGoogle NewsN/A
[Representative Jackie Speier US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
[Representative Jerrold Nadler US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
[Representative Katie Porter US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Legislative Citation

APA
US HB9321 | 2021-2022 | 117th Congress. (2022, November 17). LegiScan. Retrieved December 26, 2024, from https://legiscan.com/US/bill/HB9321/2021
MLA
"US HB9321 | 2021-2022 | 117th Congress." LegiScan. LegiScan LLC, 17 Nov. 2022. Web. 26 Dec. 2024. <https://legiscan.com/US/bill/HB9321/2021>.
Chicago
"US HB9321 | 2021-2022 | 117th Congress." November 17, 2022 LegiScan. Accessed December 26, 2024. https://legiscan.com/US/bill/HB9321/2021.
Turabian
LegiScan. US HB9321 | 2021-2022 | 117th Congress. 17 November 2022. https://legiscan.com/US/bill/HB9321/2021 (accessed December 26, 2024).

Subjects


US Congress State Sources


feedback